Primary outcome reduced by anti-inflammatory drug in chronic coronary disease

Educational information

This video was recorded during the virtual congress of the ESC 2020.

Faculty

Mark Nidorf, MD - cardiologist, Perth, Australia

Disclosures

The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of EPCCS.

Read our summary of this trial